Continuous Infusion of Dexmedetomidine Improves Renal Ischemia-reperfusion Injury in Rat Kidney

1. Engelhard K, Werner C, Eberspächer E, et al.: The effect of the alpha 2-agonist dexmedetomidine and the N-methyl-D-aspartate antagonist S(+)-ketamine on the expression of apoptosis-regulating proteins after incomplete cerebral ischemia and reperfusion in rats. Anesth Analg 2003; 96: 524-531.

2. Okada H, Kurita T, Mochizuki T, Morita K, Sato S: The cardioprotective effect of dexmedetomidine on global ischaemia in isolated rat hearts. Resuscitation 2007; 74: 538-545.

3. Hanci V, Erol B, Bektaş S, et al.: Effect of dexmedetomidine on testicular torsion/detorsion damage in rats. Urol Int 2010; 84: 105-111.

4. Lai YC, Tsai PS, Huang CJ: Effects of dexmedetomidine on regulating endotoxin-induced up-regulation of inflammatory molecules in murine macrophages. J Surg Res 2009; 154: 212-219.

5. Gu J, Chen J, Xia P, Tao G, Zhao H, Ma D: Dexmedetomidine attenuates remote lung injury induced by renal ischemia-reperfusion in mice. Acta Anaesthesiol Scand 2011; 55: 1272-1278.

6. Cerda J, Lameire N, Eggers P, et al.: Epidemiology of acute kidney injury. Clin J Am Soc Nephrol 2008; 3: 881-886.

7. Borthwick E, Ferguson A: Perioperative acute kidney injury: risk factors, recognition, management, and outcomes. BMJ 2010; 341: c3365.

8. Bonventre JV: Mechanisms of ischemic acute renal failure. Kidney Int 1993; 43: 1160-1178.

9. Li L, Okusa MD: Macrophages, dendritic cells, and kidney ischemia-reperfusion injury. Semin Nephrol 2010; 30: 268-277.

10. El Sabbahy M, Vaidya VS: Ischemic kidney injury and mechanisms of tissue repair. Wiley Interdiscip Rev Syst Biol Med 2011; 3: 606-618.

11. Lu CY, Winterberg PD, Chen J, Hartono JR: Acute kidney injury: a conspiracy of toll-like receptor 4 on endothelia, leukocytes, and tubules. Pediatr Nephrol 2011; 10: 1847-1854.

12. Kocoglu H, Ozturk H, Ozturk H, Yilmaz F, Gulcu N: Effect of dexmedetomidine on ischemia-reperfusion injury in rat kidney: a histopathologic study. Ren Fail 2009; 31: 70-74.

13. Gu J, Sun P, Zhao HR, et al.: Dexmedetomidine provides renoprotection against ischemia-reperfusion injury in mice. Crit Care 2011; 15: R153.

14. Kobayashi I, Kokita N, Namiki A: Propofol attenuates ischaemia-reperfusion injury in the rat heart in vivo. Eur J Anaesthesiol 2008; 25: 144-151.

15. Yang CC, Kuo TB, Chan SH: Auto- and crossspectral analysis of cardiovascular flucruarions during pentobarbital anesthesia in the rat. Arn J Physiol 1996; 270: H575-582.

16. Lee HT, Emala CW, Joo JD, Kim M: Isoflurane improves survival and protects against renal and hepatic injury in murine septic peritonitis. Shock 2007; 27: 373-379.

17. Bol CJJG, Danhof M, Stanski DR, Mandema JW: Pharmacokinetic-Pharmacodynamic Characterization of the Cardiovascular, Hypnotic, EEG and Ventilatory Responses to Dexmedetomidine in the Rat. J Pharmacol Exp Ther 1997; 283: 1051-1058.

18. Bol CJJG, Vogelaar JP, Mandema JW: Anesthetic Profile of Dexmedetomidine Identified by Stimulus-Response and Continuous Measurements in Rats. J Pharmacol Exp Ther 1999; 291: 153-160.

19. Franken ND, van Oostrom H, Stienen PJ, Doornenbal A, Hellebrekers LJ: Evaluation of analgesic and sedative effects of continuous infusion of dexmedetomidine by measuring somatosensory- and auditory-evoked potentials in the rat. Vet Anaesth Analg 2008; 35: 424-431.

20. Chatterjee PK, Zacharowski K, Cuzzocrea S, Otto M, Thiemermann C: Inhibitors of poly (ADP-ribose) synthetase reduce renal ischemia-reperfusion injury in the anesthetized rat in vivo. FASEB J 2000; 14: 641-651.

21. Singh AP, Junemann A, Muthuraman A, et al.: Animal models of acute renal failure. Pharmacol Rep 2012; 64: 31-44.

22. Jo SK, Sung SA, Cho WY, Go KJ, Kim HK: Macrophages contribute to the initiation of ischaemic acute renal failure in rats. Nephrol Dial Transplant 2006; 21: 1231-1239.

23. Donnahoo KK, Meng X, Ao L, et al.: Differential cellular immunolocalization of renal tumour necrosis factor-alpha production during ischaemia versus endotoxaemia. Immunology 2001; 102: 53-58.

24. Fukatsu A, Matsuo S, Yuzawa Y, Miyai H, Futenma A, Kato K: Expression of interleukin 6 and major histocompatibility complex molecules in tubular epithelial cells of diseased human kidneys. Lab Investig 1993; 69: 58-67.

25. Kielar ML, John R, Bennett M, et al.: Maladaptive role of IL-6 in ischemic acute renal failure. J Am Soc Nephrol 2005; 16: 3315-3325.

26. Chen J, Hartono JR, John R, et al.: Early interleukin 6 production by leukocytes during ischemic acute kidney injury is regulated by TLR4. Kidney Int 2011; 80: 504-515.

27. Patel NS, Chatterjee PK, Di Paola R, et al.: Thiemermann C. Endogenous Interleukin-6 Enhances the Renal Injury, Dysfunction, and Inflammation Caused by Ischemia/Reperfusion. J Pharmacol Exp Ther 2005; 312: 1170-1178.

28. Dragun D, Hoff U, Park JK, et al.: Ischemia-reperfusion injury in renal transplantation is independent of the immunologic background. Kidney Int 2000; 58: 2166-2177.

29. Forstermann U, Closs EI, Pollock JS: Nitric oxide synthase isozymes. Characterization, purification, molecular cloning, and functions. Hypertension 1994; 23: 1121-1131.

30. Mount PF, Power DA: Nitric oxide in the kidney: functions and regulation of synthesis. Acta Physiol 2006; 187: 433-446.

31. Kwon O, Hong SM, Ramesh G: Diminished NO generation by injured endothelium and loss of macula densa nNOS may contribute to sustained acute kidney injury after ischemia-reperfusion. Am J Physiol Renal Physiol 2009; 296: F25-33.

32. Mattson DL, Wu F: Nitric Oxide Synthase Activity and Isoforms in Rat Renal Vasculature. Hypertension 2000; 35: 337-341.

33. Chatterjee PK, Zacharowski K, Cuzzocrea S, et al.: Lipoteichoic acid from Staphylococcus aureus reduces renal ischemia/reperfusion injury. Kidney Int 2002; 62: 1249-1263.

34. Snapir A, Talke P, Posti J, Huiku M, Kentala E, Scheinin M: Effects of nitric oxide synthase inhibition on dexmedetomidine-induced vasoconstriction in healthy human volunteers. Br J Anaesth 2009; 102: 38-46.

35. Dyck JB, Maze M, Haack C, Azarnoff DL, Vuorilehto L, Shafer SL: Computer-controlled infusion of intravenous dexmedetomidine hydrochloride in adult human volunteers. Anesthesiology 1993; 78: 821-828.

36. Talke P, Richardson CA, Scheinin M, Fisher DM: Postoperative pharmacokinetics and sympatholytic effects of dexmedetomidine. Anesth Analg 1997; 85: 1136-1142.

37. Khan ZP, Ferguson CN, Jones RM: alpha-2 and imidazoline receptor agonists. Their pharmacology and the rapeutic role. Anaesthesia 1999; 54: 146-165.

38. Yang CL, Tsai PS, Huang CJ: Effects of Dexmedetomidine on Regulating Pulmonary Inflammation in a Rat Model of Ventilator-induced Lung Injury. Acta Anaesthesiol Taiwan 2008; 46: 151-159.

39. Yuzbasioglu MF, Aykas A, Kurutas EB, Sahinkanat T: Protective effects of propofol against ischemia/reperfusion injury in rat kidneys. Ren Fail 2010; 32: 578-583.

40. Lee HT, Ota-Setlik A, Fu Y, Nasr SH, Emala CW: Differential protective effects of volatile anesthetics against renal ischemia-reperfusion injury in vivo. Anesthesiology 2004; 101: 1313-1324.

41. Habibey R, Ajami M, Ebrahimi SA, Hesami A, Babakoohi S, Pazoki-Toroudi H: Nitric oxide and renal protection in morphine-dependent rats. Free Radic Biol Med 2010; 49: 1109-1118.

42. Marangoni MA, Hausch A, Vianna PT, Braz JR, Viero RM, Castiglia YM: Renal function and histology after acute hemorrhage in rats under dexmedetomidine action. Acta Cir Bras 2007; 22: 291-298.

43. Moreira TS, Takakura AC, Menani JV, Colombari E: Involvement of central alpha 1- and alpha 2-adrenoceptors on cardiovascular responses to moxonidine. Eur J Pharmacol 2007; 563: 164-171.

44. Moreira TS, Takakura AC, Menani JV, Sato MA, Colombari E: Central blockade of nitric oxide synthesis reduces moxonidine-induced hypotension. Br J Pharmacol 2004; 142: 765-771.

45. Taniguchi T, Kidani Y, Kanakura H, Takemoto Y, Yamamoto K: Effects of dexmedetomidine on mortality rate and inflammatory responses to endotoxin-induced shock in rats. Crit Care Med 2004; 32: 1322-1326.

46. Bylund DB: Subtypes of alpha 1- and alpha 2-adrenergic receptors. FASEB J 1992; 6: 832-839.